The process for developing new biotech therapies can easily put R&D and intellectual property leaders in uncharted territory. From lead selection to freedom to operate, it is not unusual to request a dozen patent and scientific literature searches to help guide researchers as they attempt to maximize value and opportunity. Collaboration, communication, and thorough research facilitate the innovation to commercialization lifecycle.
Join us on Thursday, April 27, 2023, at 12 PM ET, when Gene Quinn, Founder, President & CEO of IPWatchdog, will be joined by Matthew J. McBride, Director of CAS IP ServicesSM, Amy Fix, Partner at Barnes & Thornburg, and Dr. John Astor Cleveland, Jr., General Patent Counsel at Assembly Biosciences, as they share their unique perspectives on how R&D and IP teams can develop holistic approaches for driving IP value during R&D. The panel will discuss comprehensive patent and search strategies, from pinpointing the best opportunities for lead selection to ensuring freedom to operate ahead of clinical trials, and much more.
In addition to answering questions, during this webinar, the panel will discuss the following:
At CAS, we curate, connect, and analyze scientific knowledge to reveal the unseen connections that inspire breakthroughs. We weave a fabric of discovery that scientific innovators can tap into to stimulate their creativity and accelerate their work. Because when the world turns to science, science turns to CAS. So if you’re advancing research, repurposing technology, making strategic decisions, or leading digital R&D initiatives, take a look at our story below to see how partnering with us gets you there faster. A global company based in Columbus, Ohio, CAS employs over 1,400 experts who curate, connect, and analyze scientific knowledge to reveal unseen connections. CAS is a division of the American Chemical Society. Connect with us at cas.org.